David Risinger

Stock Analyst at Leerink Partners

(4.97)
# 80
Out of 4,345 analysts
1135
Total ratings
63.6%
Success rate
29.8%
Average return

Stocks Rated by David Risinger

Eli Lilly and Company
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,082.92
Upside: -
AnaptysBio
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $57.68
Upside: -
Regeneron Pharmaceuticals
May 18, 2026
Downgraded: Hold
Price Target: $641
Current: $627.74
Upside: +2.11%
Johnson & Johnson
May 15, 2026
Reiterated: Buy
Price Target: $201$265
Current: $231.29
Upside: +14.57%
ImageneBio
May 8, 2026
Maintained: Buy
Price Target: $30$24
Current: $5.89
Upside: +307.47%
Oruka Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $109$120
Current: $57.98
Upside: +106.99%
First Tracks Biotherapeutics
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $16.17
Upside: +184.48%
Centessa Pharmaceuticals
Apr 1, 2026
Downgraded: Hold
Price Target: $40
Current: $39.77
Upside: +0.58%
XOMA Royalty
Feb 24, 2026
Maintained: Buy
Price Target: $50
Current: $41.67
Upside: +19.99%
Amgen
Jan 13, 2026
Maintained: Hold
Price Target: n/a
Current: $336.06
Upside: -
Maintained: Buy
Price Target: $60
Current: $57.52
Upside: +4.31%
Maintained: Buy
Price Target: n/a
Current: $215.40
Upside: -
Maintained: Hold
Price Target: n/a
Current: $68.67
Upside: -
Maintained: Buy
Price Target: $525
Current: $437.22
Upside: +20.08%
Maintained: Buy
Price Target: n/a
Current: $77.14
Upside: -
Reiterated: Buy
Price Target: $22$32
Current: $29.58
Upside: +8.18%
Maintained: Hold
Price Target: $26
Current: $26.21
Upside: -0.80%
Reiterated: Buy
Price Target: n/a
Current: $51.02
Upside: -
Maintained: Buy
Price Target: n/a
Current: $11.88
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $44.43
Upside: -
Maintained: Buy
Price Target: n/a
Current: $30.43
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $11.04
Upside: -
Maintained: Hold
Price Target: $13
Current: $16.28
Upside: -20.12%
Maintained: Buy
Price Target: $60$44
Current: $39.54
Upside: +11.28%
Maintained: Sell
Price Target: $27$23
Current: $47.61
Upside: n/a
Initiated Coverage: Buy
Price Target: $28
Current: $65.21
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $3.71
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $54.70
Upside: n/a
Maintained: Hold
Price Target: $91
Current: $133.69
Upside: n/a
Maintained: Buy
Price Target: n/a
Current: $11.48
Upside: n/a
Initiated Coverage: Hold
Price Target: $33
Current: $13.38
Upside: n/a
Reiterated: Hold
Price Target: $176
Current: $237.56
Upside: n/a
Maintained: Sell
Price Target: $20$22
Current: $32.89
Upside: n/a
Maintained: Buy
Price Target: $90
Current: $120.24
Upside: n/a
Maintained: Hold
Price Target: $18$16
Current: $16.29
Upside: n/a
Maintained: Hold
Price Target: $53$45
Current: $11.16
Upside: n/a
Maintained: Hold
Price Target: $48.34
Current: $7.45
Upside: n/a
Maintained: Hold
Price Target: $16$22
Current: $38.09
Upside: n/a
Maintained: Sell
Price Target: $8$9
Current: $34.56
Upside: n/a
Maintained: Buy
Price Target: $31$41
Current: $23.69
Upside: n/a
Maintained: Hold
Price Target: $167$174
Current: $79.48
Upside: n/a
Initiated Coverage: Hold
Price Target: $51
Current: $53.97
Upside: n/a
Maintained: Hold
Price Target: $18$3
Current: $12.78
Upside: n/a
Maintained: Hold
Price Target: $5
Current: $23.41
Upside: n/a
Upgraded: Hold
Price Target: n/a
Current: $267.01
Upside: n/a
Maintained: Buy
Price Target: $36
Current: $190.96
Upside: n/a